Prediction and reversion of post-transplant relapse in patients with chronic myeloid leukemia using mixed chimerism and residual disease detection and adoptive immunotherapy
- 30 April 2000
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 24 (4) , 339-347
- https://doi.org/10.1016/s0145-2126(99)00185-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cellsBone Marrow Transplantation, 1998
- Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMTBone Marrow Transplantation, 1998
- Donor Lymphocyte Infusion for the Treatment of Relapse after Allogeneic Hematopoietic Stem Cell TransplantationLeukemia & Lymphoma, 1998
- Persistent donor chimaerism is consistent with disease-free survival following BMT for chronic myeloid leukaemiaBone Marrow Transplantation, 1997
- Sequential molecular monitoring of chimerism in chronic myeloid leukemia patients receiving donor lymphocyte transfusion for relapse after bone marrow transplantationBone Marrow Transplantation, 1997
- Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft‐versus‐host disease and relapseBritish Journal of Haematology, 1993
- Sex identification by polymerase chain reaction using X‐Y homologous primerAmerican Journal of Medical Genetics, 1991
- Rapid Detection of Hypervariable Regions by the Polymerase Chain Reaction TechniqueDNA and Cell Biology, 1990
- PRENATAL SEX DETERMINATION BY DNA AMPLIFICATION FROM MATERNAL PERIPHERAL BLOODThe Lancet, 1989
- Bone Marrow Transplantation for Patients with Chronic Myeloid LeukemiaNew England Journal of Medicine, 1986